These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1605155)

  • 21. Severe neuropathy associated with low-dose recombinant interferon-alpha.
    Gastineau DA; Habermann TM; Hermann RC
    Am J Med; 1989 Jul; 87(1):116. PubMed ID: 2741970
    [No Abstract]   [Full Text] [Related]  

  • 22. Imaging in small and medium vessel vasculitis.
    Singhal M; Gupta P; Sharma A
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():78-85. PubMed ID: 30698353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rheumatoid arthritis-like disease after alpha-interferon therapy.
    Chazerain P; Meyer O; Kahn MF
    Ann Intern Med; 1992 Mar; 116(5):427. PubMed ID: 1736783
    [No Abstract]   [Full Text] [Related]  

  • 24. Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa.
    Larrey D; Marcellin P; Fréneaux E; Pessayre D; Benhamou JP
    JAMA; 1989 Apr; 261(14):2065. PubMed ID: 2494361
    [No Abstract]   [Full Text] [Related]  

  • 25. Nephrotic range of proteinuria and interferon therapy.
    Weiss KS
    Ann Intern Med; 1992 Feb; 116(4):347. PubMed ID: 1733397
    [No Abstract]   [Full Text] [Related]  

  • 26. Cerebral vasculitis and hemorrhage associated with phenylpropanolamine.
    Fallis RJ; Fisher M
    Neurology; 1985 Mar; 35(3):405-7. PubMed ID: 3974900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients.
    Kramer P; ten Kate FW; Bijnen AB; Jeekel J; Weimar W
    Lancet; 1984 May; 1(8384):989-90. PubMed ID: 6143968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-interferon therapy and cutaneous vascular lesions.
    Dreno B; Huart A; Billaud E; Litoux P; Godefroy WY
    Ann Intern Med; 1989 Jul; 111(1):95-6. PubMed ID: 2786685
    [No Abstract]   [Full Text] [Related]  

  • 29. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.
    Rönnblom LE; Alm GV; Oberg KE
    Ann Intern Med; 1991 Aug; 115(3):178-83. PubMed ID: 2058872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Behçet disease and exogenous interferon. A successful treatment study using recombinant alpha-A-IFN].
    Stadler R; Bratzke B; Baumann I
    Hautarzt; 1987 Feb; 38(2):97-100. PubMed ID: 3570783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hazards of interferon therapy in chronic granulocytic leukaemia.
    Jacobs P; Wood L
    S Afr Med J; 1997 Oct; 87(10):1394. PubMed ID: 9472263
    [No Abstract]   [Full Text] [Related]  

  • 32. Digital vasculitis: a late complication of anti-tumour necrosis factor alpha therapy.
    Mangat P; Whittle S; Cleland L; Limaye V
    Clin Rheumatol; 2008 Dec; 27(12):1593-5. PubMed ID: 18827960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune thrombocytopenia and interferon alfa.
    Kanfer EJ; McCarthy DM
    BMJ; 1988 Dec; 297(6663):1613. PubMed ID: 3147106
    [No Abstract]   [Full Text] [Related]  

  • 34. Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C.
    Marcellin P; Pouteau M; Renard P; Grynblat JM; Colas Linhart N; Bardet P; Bok B; Benhamou JP
    Gut; 1992 Jun; 33(6):855-6. PubMed ID: 1624172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of side-effects of interferon.
    Visco G; Boumis E; Noto P; Comandini UV
    Lancet; 1991 Mar; 337(8743):741. PubMed ID: 1672212
    [No Abstract]   [Full Text] [Related]  

  • 36. Ischaemic jejunal vasculitis during treatment with pegylated interferon-alpha 2b and ribavirin for hepatitis C virus related cirrhosis.
    Pompili M; Pizzolante F; Larocca LM; Covino M; Rapaccini GL; Gasbarrini G
    Dig Liver Dis; 2006 May; 38(5):352-4. PubMed ID: 16169782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raynaud's phenomenon and cryoglobulinaemia associated with the use of recombinant human alpha-interferon.
    Roy V; Newland AC
    Lancet; 1988 Apr; 1(8591):944-5. PubMed ID: 2895871
    [No Abstract]   [Full Text] [Related]  

  • 38. Recombinant human interferon gamma: adverse effects in high-risk stage I and II cutaneous malignant melanoma.
    Meyskens FL; Kopecky K; Samson M; Hersh E; Macdonald J; Jaffe H; Crowley J; Coltman C
    J Natl Cancer Inst; 1990 Jun; 82(12):1071. PubMed ID: 2112201
    [No Abstract]   [Full Text] [Related]  

  • 39. Liver failure due to recombinant alpha interferon for chronic myelogenous leukaemia.
    Wandl UB; Kloke O; Niederle N
    Lancet; 1992 Jan; 339(8785):123-4. PubMed ID: 1345846
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of hyperthyroidism by interferon-alpha-2b.
    Schultz M; Müller R; von zur Mühlen A; Brabant G
    Lancet; 1989 Jun; 1(8652):1452. PubMed ID: 2567459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.